PPAR: A mediator of peroxisome proliferator action
Long-term injectable use requires ongoing prescription management, pharmacy access, and proper storage infrastructure
Pediatrics: No adverse effects were noted following IV infusion of acetylcysteine at a mean rate of 4.2 mg/kg per hour for 24 hours in 10 preterm infants (gestational age of 25-31 weeks and weight of 500-1380 g) or following infusion of acetylcysteine 0.1-1.3 mg/kg per hour for 6 days in 6 neonates (gestational age of 26-30 weeks and weight of 520-1335 g)
Following a washing step, Alexa Fluor 594-conjugated goat anti-rabbit IgG (1:400, Molecular Probes, Waltham, MA, USA) and/or Alexa Fluor 488-conjugated goat anti-mouse IgG (1:400, Molecular Probes) were/was added as the secondary antibody and DAPI was used for nuclear staining
Eves-van den Akker S, Lilley C, Danchin E, Rancurel C, Cock P, Urwin P, et al
Ideal for anyone seeking improved health or managing chronic conditions